# Attenuation of Corticosteroid Induced Hippocampal Changes

> **NCT01656187** · PHASE4 · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 46 (actual)

## Conditions studied

- Organic Memory Impairment

## Interventions

- **DRUG:** Memantine 10 mg capsule
- **DRUG:** Memantine-matched Placebo capsule

## Key facts

- **NCT ID:** NCT01656187
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2019-03-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01656187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01656187, "Attenuation of Corticosteroid Induced Hippocampal Changes". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01656187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*